Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VUMERITY® safely and effectively. See full prescribing information for VUMERITY. VUMERITY® (diroximel fumarate) delayed-release capsules, for oral useInitial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-prescription
VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
- generic_name
- diroximel fumarate
- product_names
- diroximel fumarate
- ndc
- 64406-020, 64406-020-01, 64406-020-03, 64406-020-05, 64406-020-07
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en